← Back to patent-cliff list
马来酸西布曲明
Tier C — Watch / tradeSibutramine maleate
Abbott Laboratories
Originator
2011
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：NET、SERT、DAT
Indications (approved)：神经性厌食
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sibutramine maleate?
Approved indications include: 神经性厌食.
When does the Sibutramine maleate patent expire?
No public expiry year is available for Sibutramine maleate yet; this page updates once verified.
How do I get a quote for Sibutramine maleate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24